| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Nolet Chris | Director | C/O ARRIVENT BIOPHARMA, INC., 18 CAMPUS BOULEVARD SUITE 100, NEWTOWN SQUARE | By: /s/ James Kastenmayer, Attorney-in-Fact for Chris Nolet | 20 Jun 2025 | 0001782814 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVBP | Non-Qualified Stock Option (right to buy) | Award | $0 | +15,502 | $0.000000 | 15,502 | 18 Jun 2025 | Common Stock | 15,502 | $24.89 | Direct |